Trexquant Investment LP Buys 604,116 Shares of Teladoc Health, Inc. $TDOC

Key Points

• Trexquant Investment LP increased its holdings in Teladoc Health, Inc. by 198.9% during Q1 2023, now owning approximately 0.52% of the company worth $7.23 million.
• Several other hedge funds also made significant changes to their positions in Teladoc Health, with institutional investors now owning 76.82% of the stock.
• Analysts have mixed views on Teladoc Health, with a consensus rating of "Hold" and varying price targets, the highest being $10.00 and the lowest at $7.00.

Trexquant Investment LP raised its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 198.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 907,859 shares of the health services provider's stock after buying an additional 604,116 shares during the period. Trexquant Investment LP owned about 0.52% of Teladoc Health worth $7,227,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Mercer Global Advisors Inc. ADV increased its stake in shares of Teladoc Health by 9.6% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider's stock worth $113,000 after purchasing an additional 1,089 shares in the last quarter. Vise Technologies Inc. increased its stake in shares of Teladoc Health by 4.9% in the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock worth $274,000 after purchasing an additional 1,405 shares in the last quarter. Westside Investment Management Inc. increased its stake in shares of Teladoc Health by 16.8% in the 1st quarter. Westside Investment Management Inc. now owns 10,750 shares of the health services provider's stock worth $86,000 after purchasing an additional 1,550 shares in the last quarter. National Bank of Canada FI increased its stake in shares of Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,581 shares in the last quarter. Finally, Golden State Wealth Management LLC increased its stake in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares in the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TDOC has been the subject of several analyst reports. Bank of America reduced their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Mizuho initiated coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price objective for the company. Evercore ISI upped their price objective on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Truist Financial reduced their price objective on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research note on Tuesday, May 27th. Finally, Wells Fargo & Company cut their price target on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Six equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Teladoc Health has an average rating of "Hold" and an average price target of $9.80.

Teladoc Health Price Performance

TDOC stock traded down $0.08 during trading on Tuesday, reaching $7.65. The company's stock had a trading volume of 4,512,235 shares, compared to its average volume of 5,485,458. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $1.35 billion, a P/E ratio of -6.43 and a beta of 1.84. The company's fifty day moving average is $7.80 and its 200-day moving average is $7.94.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The business had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. During the same quarter in the prior year, the business posted ($0.38) EPS. Teladoc Health's revenue for the quarter was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.